Revvity (LTS:0KHE) Total Current Liabilities: $1,239 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0KHE Revvity Inc LTS:0KHE
75 GF Score
Price $110.37
GF Value $119.77
Valuation Fairly Valued
! 11 Warning Signs
View Full Analysis

What is Revvity Total Current Liabilities?

Revvity LTS:0KHE -0.57% 75 Total Current Liabilities is $1,239 Mil as of Mar. 2026. GuruFocus rates LTS:0KHE with a GF Score™ of 75/100 and a GF Value™ of $119.77 (Fairly Valued). The stock has 11 warning signs investors should review.

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Revvity's total current liabilities for the quarter that ended in Mar. 2026 was $1,239

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Revvity Total Current Liabilities Related Terms

Revvity Total Current Liabilities Historical Data

* Premium members only.

The historical data trend for Revvity's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revvity Total Current Liabilities Chart

Revvity Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,213.74 1,544.48 1,450.46 653.10 1,331.25

Revvity Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 648.19 671.81 1,222.74 1,331.25 1,238.64
LTS:0KHE
75GF Score
Revvity Inc LTS:0KHE
Total Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Revvity Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Revvity's Total Current Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=504.061+618.863
+Other Current Liabilities+Current Deferred Liabilities
=48.128+160.194
=1,331

Revvity's Total Current Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=662.813+575.831
+Other Current Liabilities+Current Deferred Liabilities
=0+0
=1,239

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

What does a Total Current Liabilities of $1,239 Mil mean?
Revvity (LTS:0KHE) has a Total Current Liabilities of $1,239 Mil as of Mar. 2026. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Revvity and its competitors.
Is Revvity's Total Current Liabilities too high?
Revvity's current Total Current Liabilities is $1,239 Mil. Overall, Revvity has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Revvity's Total Current Liabilities compare to ICLR and CRL?
Revvity's Total Current Liabilities of $1,239 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Liabilities for a Medical Diagnostics & Research company?
A good Total Current Liabilities depends on the Medical Diagnostics & Research industry context. However, Total Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Liabilities mean?
A high Total Current Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Revvity and its competitors. Revvity's current Total Current Liabilities is $1,239 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revvity stock overvalued right now?
Based on GuruFocus' analysis, Revvity (LTS:0KHE) is currently considered Fairly Valued. The stock's GF Value™ is $119.77, compared to a current price of $110.37 — trading 7.8% below its estimated fair value. The current Total Current Liabilities is $1,239 Mil. Revvity's overall GF Score™ is 75/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Liabilities calculated?
Total Current Liabilities is calculated from a company's financial statements. For Revvity (LTS:0KHE), the current Total Current Liabilities is $1,239 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Revvity (LTS:0KHE) Overvalued in 2026?

Based on GuruFocus' analysis, Revvity stock appears to be undervalued. The current stock price of $110.37 is trading 7.8% below its estimated GF Value™ of $119.77. GuruFocus considers Revvity to be Fairly Valued.

Key valuation signals for LTS:0KHE:

  • Total Current Liabilities: $1,239 Mil
  • GF Value™: $119.77 vs. price of $110.37 (7.8% below fair value)
  • GF Score™: 75/100 with 11 warning signs

No single metric tells the full story. See the LTS:0KHE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Revvity Business Description

Address 77 4th Avenue, Waltham, MA, USA, 02451
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
75GF Score

Get the complete analysis for LTS:0KHE

Total Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$110.37
Price
$119.77
GF Value